Gossamer Bio is trading at $10.81 (-9.42%), likely reflecting profit-taking after its recent rally.
- Shares gained 8.94% on September 17 and 5.59% on September 16.
- No clear company-specific announcement explains the September 18 decline; recent coverage centers on the board appointment and reverse split.
- Biotech-sector strength makes a sector-driven explanation unlikely, leaving profit-taking and volatility as the most likely interpretation.